At the news
? NEUTRALIMPACT 3/10 8-K filed Apr 10, 2026 at 16:01 ET
Vir Biotechnology's Chief Medical Officer, Mark Eisner, is stepping down effective April 24, 2026, and the company has begun a search for his successor. This is a C-suite departure but no immediate replacement was named.
- Dr. Mark Eisner, Executive Vice President and Chief Medical Officer, is stepping down effective April 24, 2026.
- He informed the company of his departure on April 7, 2026.
- The company has initiated a search for a successor but has not named an interim or permanent replacement.
- No reason for departure was specified beyond 'stepping down'.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access